Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study

Efficacy and Safety of Tofacitinib Retreatment for Ulcerative Colitis After Treatment Interruption: Results From the OCTAVE Clinical Trials

(2021) Julian Panés et al.   Journal of Crohns & Colitis

Tofacitinib for rescue therapy in acute severe ulcerative colitis: a real-world experience

(2020) Prashant Kotwani et al.   Journal of Crohns & Colitis

Baseline Clearance of Infliximab is Associated with Requirement for Colectomy in Patients with Acute Severe Ulcerative Colitis

(2020) Robert Battat et al.   Clinical Gastroenterology and Hepatology

Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience

(2020) Sailish Honap et al.   Journal of Crohns & Colitis

Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center

(2019) Shail M. Govani et al.   DIGESTIVE DISEASES AND SCIENCES

Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

(2018) Stephen Hanauer et al.   Clinical Gastroenterology and Hepatology

Efficacy of Induction Therapy with High-intensity Tofacitinib in 4 Patients with Acute Severe Ulcerative Colitis

(2018) Jeffrey A. Berinstein et al.   Clinical Gastroenterology and Hepatology

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

(2017) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study

(2017) Akbar K Waljee et al.   BMJ-British Medical Journal

Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study

(2017) Akbar K Waljee et al.   BMJ-British Medical Journal

Review article: the practical management of acute severe ulcerative colitis

(2016) D. Seah et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis

(2015) David J. Gibson et al.   Clinical Gastroenterology and Hepatology

Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis

(2015) Johannan F. Brandse et al.   GASTROENTEROLOGY

Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit

(2013) R. W. Lynch et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Comparison of imputation methods for missing laboratory data in medicine

(2013) Akbar K Waljee et al.   BMJ Open

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

(2012) David Laharie et al.   LANCET

Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

(2012) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

The pattern and outcome of acute severe colitis

(2010) Lotte C. Dinesen et al.   Journal of Crohns & Colitis